ArticleFrontiers in oncology2026
Evaluation of an interpretable deep-learning model for the automated plan review of intensity-modulated radiation therapy.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intensity-modulated radiation therapy (IMRT) is a treatment modality for delivering a higher radiation dose to the target using multiple radiation beams from various gantry angles. Since an IMRT plan is complex and presents a high risk, quality assurance is crucial. In routine clinical practice, a radiotherapy treatment plan review is manually conducted by experienced planners to ensure the high quality and reliability of an IMRT plan. To assist this procedure, several machine-learning methods have been developed to automatically identify outliers or anomalous plans from a large amount of treatment plans. Purpose: Due to the highly complex and non-linear nature of most machine-learning methods, their results are less explainable, and therefore, cannot be fully trusted by clinical users. To alleviate this issue, an unsupervised deep-learning model with an interpretable tool was introduced and evaluated on our clinical database. Methods: Six hundred IMRT treatment plans were collected from our institute and the relevant features were extracted. A standard autoencoder (AE) was used to build an anomaly detection model from the normal plans and identify anomalies with exceptionally high reconstruction errors. To help explain the model output, a feature perturbation interpretation (FPI) method was introduced to rank the impacts of the features on the detected anomalies. To validate the effectiveness of the FPI method, the feature ranks provided by the local depth-based isolation forest feature importance (Local-DIFFI) and SHapley Additive exPlanations (SHAP) methods were compared. In addition, the effectiveness of the FPI method was evaluated on the other four classic detection models, local discrete factor (LOF), density-based spatial clustering of applications with noise (HDBSCAN), one class of support vector machines (OC-SVM), and principal component analysis (PCA). Results: The AE achieved the best detection performance among all the methods. The area under the curve (AUC) value of the AE was 0.98, and the average accuracy, precision, and F1 score were 0.91, 0.61, and 0.74, respectively. The top five features with the largest impacts on the detected anomalies obtained by FPI, local-DIFFI, and SHAP are the same. Conclusion: The AE is an effective deep-learning model in identifying anomalous plans compared to classic detection models. The FPI method is universal and a reliable tool in determining the feature impact on the anomalies. Their combination provided a highly interpretable deep learning model for automatic plan review in radiotherapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.